India's Top Lawyers Harish Salve and Gopal Subramanium Set to Clash in Singapore Court

Team SoOLEGAL 23 Nov 2017 4:41pm

Image courtesy: India's top lawyers, Gopal Subramanium and Harish Salve set to clash in Singapore court India's Top Lawyers Harish Salve and Gopal Subramanium Set to Clash in Singapore Court

The Supreme Court of Singapore has allowed Former Solicitor General of India and Senior Advocate, Mr. Gopal Subramanium to appear on behalf of Daiichi Sankyo, a Japanese Pharmaceuticals company, in the proceeding in Singapore, it reports ET.

"I am looking forward to arguing in Singapore as it is a very respected jurisdiction, which has ruled on very important matters in transaction law," Subramanium told ET.

The development comes nearly a month after Harish Salve was permitted to argue the case on behalf of the Ranbaxy promoters Malvinder and Shivinder Singh who are challenging an arbitration tribunal award of April 2016, which ordered them to pay Daiichi more than Rs 2,500 crore in damages for allegedly concealing information regarding wrongdoing at Ranbaxy while selling it to the Japanese firm in 2008. The award is now valued at Rs 3,500 crore including interest and legal fees.

The Singapore court is yet to fix the date for the appeal proceedings. A lawyer close to the development said it is expected to take place in 2018. Daiichi had requested the Singapore High Court to permit Subramanium to appear in the appeal proceedings after the Singapore Court of Appeals allowed Salve to argue for the Singhs, said another lawyer close to the development. [Source ET]

Tagged: Supreme Court of Singapore   Advocate   Harish Salve   Gopal Subramanium   Daiichi Sankyo   Japanese Pharmaceuticals company   Ranbaxy   Lawyer  
Did you find this write up useful? YES 0 NO 0
Featured Members view all

New Members view all


C2RMTo Know More

Something Awesome Is In The Work









Sign-up and we will notify you of our launch.
We’ll also give some discount for your effort :)

* We won’t use your email for spam, just to notify you of our launch.